Clinical Research Directory
Browse clinical research sites, groups, and studies.
RCVR (Residual CardioVascular Risk) Prospective Study
Sponsor: CHA University
Summary
The goal of this observational study is to evaluate whether residual cardiovascular risk assessed at 1 month after percutaneous coronary intervention (PCI) is associated with long-term clinical outcomes in adult patients with coronary artery disease who are free from major adverse clinical events at 1 month after PCI. The main questions it aims to answer are: * Does residual cardiovascular risk at 1 month after PCI predict long-term net adverse clinical events? * Which components of residual cardiovascular risk are associated with subsequent adverse clinical outcomes? Participants will: * Undergo comprehensive laboratory testing at 1 month after PCI and annually thereafter. * Undergo artificial intelligence-based quantitative coronary angiographic analysis using DICOM datasets after PCI. * Be followed annually for up to 3 years after the 1-month assessment to evaluate clinical outcomes.
Official title: Residual CardioVascular Risk (RCVR) After Percutaneous Coronary Intervention: A Prospective Study
Key Details
Gender
All
Age Range
20 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-06-17
Completion Date
2029-02
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Interventions
Blood Sample
Patients' blood samples are tested at 1 month, and then annually for 3 years post-intervention to assess residual thrombotic, metabolic, and inflammatory risk.
DICOM Dataset
Patients' DICOM dataset is evaluated using artificial intelligence-based quantitative coronary analysis to assess a procedural risk.
Locations (1)
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea